Youcare Pharmaceutical Group (688658.SH): YKYY025 injection is approved for FDA clinical trials.
Yuekang Pharmaceutical (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "...
Youcare Pharmaceutical Group (688658.SH) announced that its wholly-owned subsidiary Hangzhou Tianlong Pharmaceutical Co., Ltd. (referred to as "Hangzhou Tianlong") recently received a letter from the U.S. Food and Drug Administration (FDA) approving clinical trials of YKYY025 injection to prevent lower respiratory tract diseases caused by respiratory syncytial virus (RSV).
Related Articles
Sinolink: Industrial and strategic metals may become the main players in this round of government reserve demand, with prices expected to move significantly higher.
Industrial: How do high oil prices affect US inflation and Federal Reserve actions?
EB SECURITIES: AI inflation is giving birth to a new cycle, and the price increase of optical fiber and copper-clad laminate is driving the growth of industry companies.
Sinolink: Industrial and strategic metals may become the main players in this round of government reserve demand, with prices expected to move significantly higher.
Industrial: How do high oil prices affect US inflation and Federal Reserve actions?
EB SECURITIES: AI inflation is giving birth to a new cycle, and the price increase of optical fiber and copper-clad laminate is driving the growth of industry companies.
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
